Antireflux surgery and esophageal mucosal DNA damage

Pera, 1993, Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction, Gastroenterology, 104, 510, 10.1016/0016-5085(93)90420-H Sihvo, 2000, The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?, Scand. J. Gastroenterol., 35, 1082, 10.1080/003655200451216 Lagergren, 1999, Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma, N. Engl. J. Med., 340, 825, 10.1056/NEJM199903183401101 Levine, 1997, Management of dysplasia in the columnar-lined esophagus, Gastroenterol. Clin. North Am., 26, 613, 10.1016/S0889-8553(05)70318-6 Corey, 2003, Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis, Am. J. Gastroenterol., 98, 2390, 10.1111/j.1572-0241.2003.08702.x Parrilla, 2003, Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus, Ann. Surg., 237, 291, 10.1097/01.SLA.0000055269.77838.8E Abbas, 2004, Barrett's esophagus: the role of laparoscopic fundoplication, Ann. Thorac. Surg., 77, 393, 10.1016/S0003-4975(03)01352-3 Csendes, 2004, Surgical treatment of Barrett's esophagus: 1980–2003, World J. Surg., 28, 225, 10.1007/s00268-003-6986-8 Sharma, 2004, Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma?, Am. J. Med., 117, 79S Shaheen, 2005, Does fundoplication change the risk of esophageal cancer in the setting of GERD?, Am. J. Gastroenterol., 100, 1009, 10.1111/j.1572-0241.2005.41978.x Chen, 2001, Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention, Carcinogenesis, 22, 1119, 10.1093/carcin/22.8.1119 Nestmann, 1996, Toxicological significance of DNA adducts: summary of discussions with an expert panel, Regul. Toxicol. Pharmacol., 24, 9, 10.1006/rtph.1996.0059 Salminen, 2002, Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies, Ann. Med., 34, 565, 10.1080/078538902321117779 Sihvo, 2002, Oxidative stress has a role in malignant transformation in Barrett's oesophagus, Int. J. Cancer, 102, 551, 10.1002/ijc.10755 Sihvo, 2003, Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus, J. Thorac. Cardiovasc. Surg., 126, 1952, 10.1016/j.jtcvs.2003.08.014 De Flora, 1996, DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine, Mutat. Res., 366, 197, 10.1016/S0165-1110(96)00043-7 T. Rantanen, J. Räsänen, E. Sihvo, M. Farkkila, J. Salo, The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: four-year follow-up study, Am. J. Gastroenterol., 2006, in press. DeMeester, 1986, Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients, Ann. Surg., 204, 9, 10.1097/00000658-198607000-00002 Savary, 1978 Rantanen, 1999, Functional outcome after laparoscopic or open Nissen fundoplication: a follow-up study, Arch. Surg., 134, 240, 10.1001/archsurg.134.3.240 Gupta, 1984, Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo, Proc. Natl. Acad. Sci. U.S.A., 81, 6943, 10.1073/pnas.81.22.6943 Hemminki, 1995, DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro, Carcinogenesis, 16, 1661, 10.1093/carcin/16.7.1661 Salo, 1999, Functional outcome after laparoscopic or open Nissen fundoplication, Arch. Surg., 134, 240, 10.1001/archsurg.134.3.240 Wetscher, 1995, Reflux esophagitis in humans is mediated by oxygen-derived free radicals, Am. J. Surg., 170, 552, 10.1016/S0002-9610(99)80014-2 Carlson, 2002, Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation, Am. J. Gastroenterol., 97, 1340, 10.1111/j.1572-0241.2002.05770.x